Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Muscle training with biofeedback may curb bladder leaks — trial puts it to the test

NCT ID NCT07728747

Symptom relief Sponsor: Gaziantep Islam Science and Technology University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether adding electromyographic (EMG) biofeedback to pelvic floor muscle training can improve bladder control in women with wet overactive bladder. Participants receive either bladder training alone or bladder training plus 24 supervised biofeedback sessions over 8 weeks. The goal is to see if biofeedback helps women better recognize and contract the right muscles to reduce urgency and leakage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EMG biofeedback-assisted pelvic floor muscle training plus bladder training
What this could lead to
If it works, this approach could offer a non-drug, non-surgical way to better manage urgency and leakage in women with overactive bladder.
What could go wrong
This is a small, early-stage trial with 64 participants, so results may not apply to all women. The added benefit of biofeedback over bladder training alone is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

64 people

The number who actually took part.

Started

Sep 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participants aged 18 years or older * Presence of wet overactive bladder symptoms * Detrusor overactivity confirmed by urodynamic testing * Pelvic floor muscle strength of at least 3/5 according to the Modified Oxford Scale * Ability to comply with the study procedures and complete the bladder diary Exclusion Criteria: * Neurogenic bladder * Active urinary tract infection or vulvovaginitis * Pregnancy or planning pregnancy * Urogynecological surgery within the previous 3 months * Pelvic organ prolapse stage 2 or higher according to the Pelvic Organ Prolapse Quantification system * Presence of a pacemaker or implantable defibrillator * Recent conservative or pharmacological treatment for overactive bladder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Detrusor overactivity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

overactive bladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Detrusor overactivity Overactive bladder (OAB) Urgency urinary incontinence

Contacts and locations

Locations

  • SANKO University Sani Konukoglu Application and Research Hospital

    Gaziantep, Şahinbey, 27010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.